| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |